COX-2 showed overexpression after treatment with 5-FU or 5-FU combination chemotherapy in all tumors, whether measured in biopsies obtained pre- and post- chemotherapy (4-folds increase) or in tumour-derived cells treated with 5-FU in vitro (24-folds increase). This evidence concerns the gene PTGS2 and neoplasm.